# Study Evaluating the Safety and Response of Fosbretabulin in Asian Patients With Polypoidal Choroidal Vasculopathy (PCV)

> **NCT01023295** · PHASE2 · COMPLETED · sponsor: **Mateon Therapeutics** · enrollment: 20 (actual)

## Conditions studied

- Polypoidal Choroidal Vasculopathy

## Interventions

- **DRUG:** fosbretabulin
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT01023295
- **Lead sponsor:** Mateon Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2011-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01023295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01023295, "Study Evaluating the Safety and Response of Fosbretabulin in Asian Patients With Polypoidal Choroidal Vasculopathy (PCV)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01023295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*